跳至主要内容
临床试验/TCTR20210420006
TCTR20210420006已完成不适用

Evaluation of Anti-Inflammatory Effect of Moringa oleifera Lam. and Vernonia cinerea Lozenge in smokers

Thailand Science Research and Innovation (TSRI)0 个研究点目标入组 67 人开始时间: 2021年4月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
67

研究概览

简要总结

In this study, MO leaf extract, VC extract, MO lozenges, and MO+VC lozenges showed strong antioxidant potential and anti-inflammatory activity by inhibiting the production of pro-inflammatory cytokines as IL-6 of inflamed human macrophages. Moreover, lozenges containing MO and MO+VC had a strong effect on reducing gingivitis and oral inflammation in smokers.

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Smokers aged between 18 and 65 years, smoked more than 5 cigarettes/day in the past 6 months, diagnosed by a dentist with mild or moderate oral inflammation, and healthy subjects with no allergic history to any ingredient in the lozenges.

排除标准

  • Exclusion criteria included subjects who had a history of disease including diabetes mellitus, cardiovascular, cancer, significant hepatic and renal impairment, neuro-logic and psychiatric disorder, and immunodeficiency, pregnant or breastfeeding, used drugs including antibiotics, anti-inflammatory, anticoagulants, anticonvulsants, immunosuppressive drugs within 6 months before the study visit, severe alcoholism or drug addict, and previous use of anti-inflammation or smoking cessation products within one month.

研究者

发起方
Thailand Science Research and Innovation (TSRI)

相似试验

The efficacy of lozenge on anti-oral inflammation... | 临床试验